Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (2) Bartels-Klein, Eireen (2) Beule, Dieter Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Diecke, Sebastian Dr. (1) Falcke, Martin Prof. Dr. (1) Friedrich, Corinna (1) Gerhardt, Holger Prof. Dr. (9) Haucke, Volker Professor (1) Hinz, Michael Dr. (1) Hollfinger, Irene (2) Kettenmann, Helmut Prof. Dr. (1) Kirchner, Marieluise Dr. (4) Klaus-Bergmann, Alexandra Dr. (2) Kolesnichenko, Marina Dr. (1) Kühn, Ralf Dr. (1) Perovic, Tijana (1) Popp, Oliver Dr. (2) Potente, Michael Prof. Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (2) Suarez Artiles, Lorena Dr. (1) Uyar, Bora Dr. (2) Willnow, Thomas Prof. Dr. (2) Wolf, Susanne Dr. (1) Zauber, Henrik Dr. (2) (-) Mertins, Philipp Dr. (10) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (1) Entwicklungsneurobiologie (1) Experimentelle Ultrahochfeld-MR (3) Magnetic Resonance (3) Molekulare Herz- Kreislaufforschung (1) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) (-) Proteomics (10) Psychoneuroimmunologie (1) (-) Synaptische Transmission und Plastitzität (1) Translational Bioinformatics (1) Tumorgenetik und zelluläre Stressantworten (1) Tumorheterogenität und Therapieresistenz in pädiatrischen Tumoren (1) Zelluläre Neurowissenschaften (1) 2006 (1) 2008 (1) 2011 (1) 2012 (3) 2013 (6) 2014 (4) 2015 (6) 2016 (3) 2017 (6) (-) 2018 (11) 2020 (14) 2021 (12) 2022 (20) 2023 (18) 2024 (7) 11 Ergebnisse: Active Filter: Mertins, Philipp Dr.ProteomicsSynaptische Transmission und Plastitzität2018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Juli 2018 / Nat Med Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition G.S. Wong J. Zhou J.B. Liu Z. Wu X. Xu T. Li D. Xu S.E. Schumacher J. Puschhof J. McFarland C. Zou A. Dulak L. Henderson P. Xu E. O'Day R. Rendak W.L. Liao F. Cecchi T. Hembrough S. Schwartz C. Szeto A.K. Rustgi K.K. Wong J.A. Diehl K. Jensen F. Graziano A. Ruzzo S. Fereshetian P. Mertins S.A. Carr R. Beroukhim K. Nakamura E. Oki M. Watanabe H. Baba Y. Imamura D. Catenacci A.J. Bass 13. September 2018 / Blood PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells J.D. Kahn P.G. Miller A.J. Silver R.S. Sellar S. Bhatt C. Gibson M. McConkey D. Adams B. Mar P. Mertins S. Fereshetian K. Krug H. Zhu A. Letai S.A. Carr J. Doench S. Jaiswal B.L. Ebert 01. Juli 2018 / Nat Protoc Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry P. Mertins L.C. Tang K. Krug D.J. Clark M.A. Gritsenko L. Chen K.R. Clauser T.R. Clauss P. Shah M.A. Gillette V.A. Petyuk S.N. Thomas D.R. Mani F. Mundt R.J. Moore Y. Hu R. Zhao M. Schnaubelt H. Keshishian M.E. Monroe Z. Zhang N.D. Udeshi D. Mani S.R. Davies R.R. Townsend D.W. Chan R.D. Smith H. Zhang T. Liu S.A. Carr 15. Februar 2018 / Cancer Res Adaptive and reversible resistance to Kras inhibition in pancreatic cancer cells P.Y. Chen M.D. Muzumdar K.J. Dorans R.A. Robbins A. Bhutkar A.M. Del Rosario P. Mertins J. Qiao C. Schaefer F.B. Gertler S.A. Carr T. Jacks 01. März 2018 / Nat Genet CLCN2 chloride channel mutations in familial hyperaldosteronism type II U.I. Scholl G. Stölting J. Schewe A. Thiel H. Tan C. Nelson-Williams A.A. Vichot S.C. Jin E. Loring V. Untiet T. Yoo J. Choi S. Xu A. Wu M. Kirchner P. Mertins L.C. Rump A.M. Onder C. Gamble D. McKenney R.W. Lash D.P. Jones G. Chune P. Gagliardi M. Choi R. Gordon M. Stowasser C. Fahlke R.P. Lifton 01. April 2018 / EMBO Rep SORCS1 and SORCS3 control energy balance and orexigenic peptide production A. Subkhangulova A.R. Malik G. Hermey O. Popp G. Dittmar T. Rathjen M.N. Poy A. Stumpf P.S. Beed D. Schmitz T. Breiderhoff T.E. Willnow 22. Februar 2018 / Cell Pervasive, coordinated protein-level changes driven by transcript isoform switching during meiosis Z. Cheng G.M. Otto E.N. Powers A. Keskin P. Mertins S.A. Carr M. Jovanovic G.A. Brar 01. Mai 2018 / Cancer Res Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple-negative breast cancers F. Mundt S. Rajput S. Li K.V. Ruggles A.D. Mooradian P. Mertins M.A. Gillette K. Krug Z. Guo J. Hoog P. Erdmann-Gilmore T. Primeau S. Huang D.P. Edwards X. Wang X. Wang E. Kawaler D.R. Mani K.R. Clauser F. Gao J. Luo S.R. Davies G.L. Johnson K.L. Huang C.J. Yoon L. Ding D. Fenyö M.J. Ellis R.R. Townsend J.M. Held S.A. Carr C.X. Ma 04. September 2018 / Cell Rep Transcriptional and translational differences of microglia from male and female brains D. Guneykaya A. Ivanov D. Perez Hernandez V. Haage B. Wojtas N. Meyer M. Maricos P. Jordan A. Buonfiglioli B. Gielniewski N. Ochocka C. Cömert C. Friedrich L. Suarez Artiles B. Kaminska P. Mertins D. Beule H. Kettenmann S.A. Wolf 10. September 2018 / Cancer Cell Proteomics, post-translational modifications, and integrative analyses reveal molecular heterogeneity within medulloblastoma subgroups T.C. Archer T. Ehrenberger F. Mundt M.P. Gold K. Krug C.K. Mah E.L. Mahoney C.J. Daniel A. LeNail D. Ramamoorthy P. Mertins D.R. Mani H. Zhang M.A. Gillette K. Clauser M. Noble L.C. Tang J. Pierre-François J. Silterra J. Jensen P. Tamayo A. Korshunov S.M. Pfister M. Kool P.A. Northcott R.C. Sears J.O. Lipton S.A. Carr J.P. Mesirov S.L. Pomeroy E. Fraenkel Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Juli 2018 / Nat Med Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition G.S. Wong J. Zhou J.B. Liu Z. Wu X. Xu T. Li D. Xu S.E. Schumacher J. Puschhof J. McFarland C. Zou A. Dulak L. Henderson P. Xu E. O'Day R. Rendak W.L. Liao F. Cecchi T. Hembrough S. Schwartz C. Szeto A.K. Rustgi K.K. Wong J.A. Diehl K. Jensen F. Graziano A. Ruzzo S. Fereshetian P. Mertins S.A. Carr R. Beroukhim K. Nakamura E. Oki M. Watanabe H. Baba Y. Imamura D. Catenacci A.J. Bass
13. September 2018 / Blood PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells J.D. Kahn P.G. Miller A.J. Silver R.S. Sellar S. Bhatt C. Gibson M. McConkey D. Adams B. Mar P. Mertins S. Fereshetian K. Krug H. Zhu A. Letai S.A. Carr J. Doench S. Jaiswal B.L. Ebert
01. Juli 2018 / Nat Protoc Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry P. Mertins L.C. Tang K. Krug D.J. Clark M.A. Gritsenko L. Chen K.R. Clauser T.R. Clauss P. Shah M.A. Gillette V.A. Petyuk S.N. Thomas D.R. Mani F. Mundt R.J. Moore Y. Hu R. Zhao M. Schnaubelt H. Keshishian M.E. Monroe Z. Zhang N.D. Udeshi D. Mani S.R. Davies R.R. Townsend D.W. Chan R.D. Smith H. Zhang T. Liu S.A. Carr
15. Februar 2018 / Cancer Res Adaptive and reversible resistance to Kras inhibition in pancreatic cancer cells P.Y. Chen M.D. Muzumdar K.J. Dorans R.A. Robbins A. Bhutkar A.M. Del Rosario P. Mertins J. Qiao C. Schaefer F.B. Gertler S.A. Carr T. Jacks
01. März 2018 / Nat Genet CLCN2 chloride channel mutations in familial hyperaldosteronism type II U.I. Scholl G. Stölting J. Schewe A. Thiel H. Tan C. Nelson-Williams A.A. Vichot S.C. Jin E. Loring V. Untiet T. Yoo J. Choi S. Xu A. Wu M. Kirchner P. Mertins L.C. Rump A.M. Onder C. Gamble D. McKenney R.W. Lash D.P. Jones G. Chune P. Gagliardi M. Choi R. Gordon M. Stowasser C. Fahlke R.P. Lifton
01. April 2018 / EMBO Rep SORCS1 and SORCS3 control energy balance and orexigenic peptide production A. Subkhangulova A.R. Malik G. Hermey O. Popp G. Dittmar T. Rathjen M.N. Poy A. Stumpf P.S. Beed D. Schmitz T. Breiderhoff T.E. Willnow
22. Februar 2018 / Cell Pervasive, coordinated protein-level changes driven by transcript isoform switching during meiosis Z. Cheng G.M. Otto E.N. Powers A. Keskin P. Mertins S.A. Carr M. Jovanovic G.A. Brar
01. Mai 2018 / Cancer Res Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple-negative breast cancers F. Mundt S. Rajput S. Li K.V. Ruggles A.D. Mooradian P. Mertins M.A. Gillette K. Krug Z. Guo J. Hoog P. Erdmann-Gilmore T. Primeau S. Huang D.P. Edwards X. Wang X. Wang E. Kawaler D.R. Mani K.R. Clauser F. Gao J. Luo S.R. Davies G.L. Johnson K.L. Huang C.J. Yoon L. Ding D. Fenyö M.J. Ellis R.R. Townsend J.M. Held S.A. Carr C.X. Ma
04. September 2018 / Cell Rep Transcriptional and translational differences of microglia from male and female brains D. Guneykaya A. Ivanov D. Perez Hernandez V. Haage B. Wojtas N. Meyer M. Maricos P. Jordan A. Buonfiglioli B. Gielniewski N. Ochocka C. Cömert C. Friedrich L. Suarez Artiles B. Kaminska P. Mertins D. Beule H. Kettenmann S.A. Wolf
10. September 2018 / Cancer Cell Proteomics, post-translational modifications, and integrative analyses reveal molecular heterogeneity within medulloblastoma subgroups T.C. Archer T. Ehrenberger F. Mundt M.P. Gold K. Krug C.K. Mah E.L. Mahoney C.J. Daniel A. LeNail D. Ramamoorthy P. Mertins D.R. Mani H. Zhang M.A. Gillette K. Clauser M. Noble L.C. Tang J. Pierre-François J. Silterra J. Jensen P. Tamayo A. Korshunov S.M. Pfister M. Kool P.A. Northcott R.C. Sears J.O. Lipton S.A. Carr J.P. Mesirov S.L. Pomeroy E. Fraenkel